New brain drain device could help older adults walk better

NCT ID NCT06498960

Ongoing Disease control Sponsor: CereVasc Inc Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the eShunt System for treating normal pressure hydrocephalus, a condition that causes trouble walking, thinking, and bladder control in older adults. The device drains extra fluid from the brain through a small tube. Researchers will compare it to the standard treatment (VP shunt) in 230 people aged 60 and older. The main goal is to see if walking improves after 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: eShunt System (a device that drains fluid from the brain)
What this could lead to: If successful, this device could offer a less invasive alternative to standard shunts, improving walking and daily function in older adults with normal pressure hydrocephalus.
What could go wrong: This is a pivotal trial, but results are not yet available. The device may not improve symptoms as hoped, and risks include infection, bleeding, or device malfunction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

normal pressure hydrocephalus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NORMAL PRESSURE HYDROCEPHALUS

Contacts and locations

Locations

Advocate Lutheran General Hospital

Park Ridge, Illinois, 60068, United States
Albany Medical Center

Albany, New York, 12208, United States
Baptist Medical Center - Jacksonville

Jacksonville, Florida, 32207, United States
Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States
Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Cleveland Clinic

Cleveland, Ohio, 44195, United States
Clinica La Sagrada Familia

Buenos Aires, C1426B, Argentina
Cooper Neurological Institute

Camden, New Jersey, 08103, United States
Henry Ford Health

West Bloomfield, Michigan, 48322, United States
Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States
Indiana University

Indianapolis, Indiana, 46202, United States
Lenox Hill Hospital

New York, New York, 10075, United States
Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Milton S. Hershey Medical Center

Hershey, Pennsylvania, 17033, United States
Montefiore Medical Center

The Bronx, New York, 10467, United States
NYU Langone Health

New York, New York, 10016, United States
Northwell Health

Manhasset, New York, 11030, United States
Northwestern University

Chicago, Illinois, 60611, United States
Rhode Island Hospital

Providence, Rhode Island, 02903, United States
St. Michael's Hospital

Toronto, Ontario, M5C 2W6, Canada
Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States
University at Buffalo Neurosurgery

Buffalo, New York, 14203, United States
University of Calgary - Foothills Medical Centre

Calgary, Alberta, T2N 4N1, Canada
University of Kansas Medical Center

Kansas City, Kansas, 66160, United States
University of Kentucky Research Foundation

Lexington, Kentucky, 40506, United States
University of Rochester Medical Center

Rochester, New York, 14642, United States
University of South Florida

Tampa, Florida, 33606, United States
University of Southern California

Los Angeles, California, 90033, United States
University of Texas Southwestern Medical Center

Dallas, Texas, 75390, United States
Virginia Commonwealth University

Richmond, Virginia, 23298, United States
Weill Cornell Medicine

New York, New York, 10065, United States
Yale University

New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.